"The short answer is we don't know and they are unlikely to disclose even an approximate date for the meeting and/or response."
The company has no obligation to report on when an FDA meeting is held nor upon what was discussed nor reveal the FDA's responses. The only prohibition on Ampio is that the company not lie about the FDA meeting IF they choose to reveal that it took place.
Ampio will only release information if the FDA indicates they will accept a BLA based on available information.
'No news' is bad news.
"I just hope the InTouch equipment in Rochester scares up a few bucks."
Doesn't Intel have claim to UnXL's equipment by virtue of the $%mil payment RK scammed from them?
"These boiler room, basher swine, hollow heads, are so original"
Writes druggie twice.
"Posts containing the word “scam” 1090394" uh 1090395.
Over a million warnings that UnXL was a scam and some people are still pumping it?
"From Dr Bar Or's recently published scientific paper - "We think that the findings presented
in this investigation, however, demonstrate that LMWF5A can..."
Looks like LMWF5A didn't work out as hoped for- no growth apparent. Do you think that Bar Or et al did experiments pre trials or chose to not do so in order to hype the possibility without being liable for, ahem, misdirection?
"THESE ARE THE REALLY SCARY BUT TRUE FACTS!!!! "
As is longs cheering a 40 cents rise from the all time low.
Downright Nixonian- When you're getting your s kicked declare victory and leave before you lose everything.
"They reported on 106 of 359 patients in the trial."
They reported on 106 eyes of 359 patients in the trial.
"I think we need a fuller report on the data."
I think you're right.
106 eyes is 53 people if both eyes were affected. Given management's history of massaging released data and FDA's aversion to data mining( based on BMI? body mass index?) I think this is going to be an opportunity to further disappoint shareholders.
"Furthermore, we successfully identified a subgroup of patients based on BMI (n= 106 eyes) in which treatment with the optimal Optina dose resulted in significant improvements in both vision and retinal swelling."
" My hope is for a blow-off bottom on Monday, likely below $2. Absent news, that is the best case."
You're not getting it. This is and always was a full on scam. You got got.
Consider that management is in on the destruction of UnXL and has taken short positions, which as proprietary trading strategy, do not have to be reported. Wouldn't it be in their best interest to run this company into bankruptcy?
" Vaughn Clift, you are such a failure. You need to leave the company. You have failed Dr. Bar-O "
Cliff is a success, he got you to buy into this scam.
No one failed Dr. Bar- Or, his theories were proven to be unsustainable.
" I hope UNXL will try to get commercial bank financing. "
Without profits revenue won't matter. Without collateral no bank will finance a company like UnXL.
"Shareholders are being asked to ratify the terms of issuance and sale of the Company's Senior Secured Convertible Notes"
The company is asking for more death spiral bullets to be issued. Nearly everyone who buys Notes, if any, will be shorting the stock.
" No news on when FDA meeting will take place."
Currently AMPE or any pharma is under no obligation to report when a meeting has taken or will take place nor what was said at such a meeting. The rule being batted about for more transparency is NOT in effect. AMPE's only prohibition is to avoid lying regarding the occurrence or outcome of such a meeting. No news is not necessarily good news.
AMPE has no management confidence from investors nor any viable or likely candidates. The stock is trading at the bid which is trending down.
There is no long shot chance. There is no magic here.
UnLike InTouch which is technically unobtainable.
Check out the order book- bid holding at $2.81. UnXL will soon be a $1.++ stock.
"Roger, prove it...Where is your proof?"
UnXL is abandoning the InTouch production lines and taking over X Sense. If they don't produce InTouch how will they generate revenue from InTouch?
Doesn't Intel still have a claim on the printing/plating equipment in Rochester?
"and will receive 100% of the revenue to be announced." 100% of the revenue from InTouch will be 0.
"What's the cash value?"
With the added HB shares and after the payments to Atmel/CIT the CV will be around 30 cents per share. That is before the operating expenses are paid.
" Never in what I said was I condoning lying."
"Lying has become a widely accepted method."
Accepted by the poster, maybe?
"Learn how to communicate."